9 employees
EnPlusOne Biosciences provides innovative solutions for emerging RNA therapeutics.
2022
$12M
from 3 investors over 3 rounds
EnPlusOne Biosciences raised $12M on September 30, 2022
Investors: Coatue Management, Breakout Ventures and Northpond Ventures